Celldex Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $8.4M | 201k | 41.97 |
| 2023-12-31 | $6.7M | 169k | 39.66 |
| 2023-09-30 | $4.5M | 164k | 27.52 |
| 2023-06-30 | $5.5M | 162k | 33.93 |
| 2023-03-31 | $5.9M | 165k | 35.98 |
| 2022-12-31 | $7.5M | 169k | 44.57 |
| 2022-09-30 | $3.2M | 163k | 19.61 |
| 2022-06-30 | $4.0M | 150k | 26.97 |
| 2022-03-31 | $5.2M | 154k | 34.07 |
| 2021-12-31 | $5.9M | 154k | 38.64 |
| 2021-09-30 | $9.3M | 173k | 53.99 |
| 2021-06-30 | $3.9M | 116k | 33.45 |
| 2021-03-31 | $1.0M | 49k | 20.60 |
| 2020-12-31 | $904k | 52k | 17.54 |
| 2020-09-30 | $280k | 19k | 14.85 |
| 2019-03-31 | $126k | 26k | 4.94 |